Hideaki Dote

970 total citations
15 papers, 779 citations indexed

About

Hideaki Dote is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Hideaki Dote has authored 15 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Genetics. Recurrent topics in Hideaki Dote's work include Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (5 papers) and Genetic Syndromes and Imprinting (4 papers). Hideaki Dote is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Cancer-related gene regulation (5 papers) and Genetic Syndromes and Imprinting (4 papers). Hideaki Dote collaborates with scholars based in Japan, United States and India. Hideaki Dote's co-authors include Kevin Camphausen, William Burgan, Philip J. Tofilon, Shinichi Toyooka, Kazunori Tsukuda, Nobuyoshi Shimizu, Masaaki Yano, Adi F. Gazdar, Mamoru Ouchida and Hiroshi Date and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Hideaki Dote

15 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideaki Dote Japan 12 627 194 138 126 92 15 779
Anchit Khanna Australia 10 512 0.8× 298 1.5× 92 0.7× 112 0.9× 50 0.5× 16 691
Kathryn M. Kinross Australia 9 409 0.7× 158 0.8× 88 0.6× 77 0.6× 100 1.1× 16 632
Susanne Radke United States 10 526 0.8× 204 1.1× 84 0.6× 56 0.4× 113 1.2× 11 695
Carter J. Barger United States 14 517 0.8× 171 0.9× 153 1.1× 77 0.6× 46 0.5× 22 708
Patricia Bukczynska Australia 13 360 0.6× 170 0.9× 126 0.9× 119 0.9× 54 0.6× 23 545
Yasemin D. Yazici United States 12 339 0.5× 269 1.4× 122 0.9× 61 0.5× 49 0.5× 14 671
Ruth J. Muschel United States 7 333 0.5× 247 1.3× 176 1.3× 55 0.4× 60 0.7× 8 517
Luis J. Schwarz Peru 10 511 0.8× 319 1.6× 317 2.3× 97 0.8× 38 0.4× 17 808
Maryland Rosenfeld-Franklin United States 8 681 1.1× 364 1.9× 272 2.0× 160 1.3× 38 0.4× 13 1.0k
Paul Crea Australia 12 531 0.8× 367 1.9× 265 1.9× 152 1.2× 49 0.5× 27 872

Countries citing papers authored by Hideaki Dote

Since Specialization
Citations

This map shows the geographic impact of Hideaki Dote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Dote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Dote more than expected).

Fields of papers citing papers by Hideaki Dote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Dote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Dote. The network helps show where Hideaki Dote may publish in the future.

Co-authorship network of co-authors of Hideaki Dote

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Dote. A scholar is included among the top collaborators of Hideaki Dote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Dote. Hideaki Dote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kobayashi, Naruyuki, Shinichi Toyooka, Junichi Soh, et al.. (2011). The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor. Lung Cancer. 75(2). 161–166. 44 indexed citations
2.
Dote, Hideaki, Koji Ohta, Rieko Nishimura, et al.. (2009). Primary extranodal non-Hodgkin’s lymphoma of the common bile duct manifesting as obstructive jaundice: Report of a case. Surgery Today. 39(5). 448–451. 8 indexed citations
3.
Tomii, Kunitoshi, Kazunori Tsukuda, Shinichi Toyooka, et al.. (2006). Aberrant promoter methylation of insulin‐like growth factor binding protein‐3 gene in human cancers. International Journal of Cancer. 120(3). 566–573. 63 indexed citations
4.
Dote, Hideaki, William Burgan, Kevin Camphausen, & Philip J. Tofilon. (2006). Inhibition of Hsp90 Compromises the DNA Damage Response to Radiation. Cancer Research. 66(18). 9211–9220. 130 indexed citations
5.
Dote, Hideaki, Shinichi Toyooka, Kazunori Tsukuda, et al.. (2005). Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. British Journal of Cancer. 92(6). 1117–1125. 66 indexed citations
6.
Dote, Hideaki, David Cerna, William Burgan, et al.. (2005). Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine. Clinical Cancer Research. 11(12). 4571–4579. 80 indexed citations
7.
Dote, Hideaki, David Cerna, William Burgan, Kevin Camphausen, & Philip J. Tofilon. (2005). ErbB3 Expression Predicts Tumor Cell Radiosensitization Induced by Hsp90 Inhibition. Cancer Research. 65(15). 6967–6975. 43 indexed citations
8.
Yano, Masaaki, Shinichi Toyooka, Kazunori Tsukuda, et al.. (2004). Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. International Journal of Cancer. 113(1). 59–66. 81 indexed citations
9.
Yano, Masaaki, Shinichi Toyooka, Kazunori Tsukuda, et al.. (2004). SYT–SSX fusion genes in synovial sarcoma of the thorax. Lung Cancer. 44(3). 391–397. 22 indexed citations
10.
Dote, Hideaki, Shinichi Toyooka, Kazunori Tsukuda, et al.. (2004). Aberrant Promoter Methylation in Human DAB2 Interactive Protein ( hDAB2IP ) Gene in Breast Cancer. Clinical Cancer Research. 10(6). 2082–2089. 91 indexed citations
11.
Dote, Hideaki, Kazunori Tsukuda, Shinichi Toyooka, et al.. (2004). Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP. Oncology Reports. 11(2). 361–3. 11 indexed citations
12.
Tsukuda, Kazunori, Masaaki Yano, Shinichi Toyooka, et al.. (2004). Less frequent promoter hypermethylation of DLC-1 gene in primary breast cancers. Oncology Reports. 12(1). 141–4. 8 indexed citations
13.
Dote, Hideaki, William Burgan, Michael Cerra, et al.. (2004). Enhanced Tumor Cell Radiosensitivity and Abrogation of G2 and S Phase Arrest by the Hsp90 Inhibitor 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin. Clinical Cancer Research. 10(23). 8077–8084. 81 indexed citations
14.
Kobatake, Takaya, Masaaki Yano, Shinichi Toyooka, et al.. (2004). Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncology Reports. 12(5). 1087–92. 47 indexed citations
15.
Dote, Hideaki, et al.. (2001). A Case of Superior Mesenteric Vein Thrombosis Caused by Protein C Deficiency.. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 62(10). 2426–2430. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026